Amgen Stock Dives 1.34% After HSBC Downgrade
Amgen stock declined by 1.34% on September 11, 2026, closing at USD 377.35 on Nasdaq.
The decrease brought Amgen shares about 15% below their 52-week high.
The downturn was triggered by a fresh rating change from HSBC to Hold from Buy, with the bank lowering its price target to $425 from $445.